Reuters logo
BRIEF-Galena Biopharma, unit of co and Biovascular, enters amendment of exclusive license agreement
September 11, 2017 / 11:33 AM / a month ago

BRIEF-Galena Biopharma, unit of co and Biovascular, enters amendment of exclusive license agreement

Sept 11 (Reuters) - Galena Biopharma Inc:

* Galena Biopharma-‍on Sept 5, unit of co and Biovascular, entered amendment of exclusive license agreement between MPI and BVI dated December 20, 2013

* Galena Biopharma - ‍pursuant to amendment parties agreed to resolve outstanding disputes over license agreement, to modify certain terms of agreement​

* Galena Biopharma- ‍amendment to eliminate 3pct royalty rate on annual net sales of $50 million, 4pct royalty now applies to annual net sales of up to $100 million​ Source text: (bit.ly/2wUfgWU) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below